Barclays’s Nutrien NTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $2.11M | Sell |
27,997
-162,236
| -85% | -$11.6M | ﹤0.01% | 2328 |
|
|
2025
Q4 | $11.7M | Buy |
190,233
+37,046
| +24% | +$2.18M | ﹤0.01% | 1570 |
|
|
2025
Q3 | $8.99M | Sell |
153,187
-66,590
| -30% | -$3.88M | ﹤0.01% | 1742 |
|
|
2025
Q2 | $12.8M | Sell |
219,777
-35,461
| -14% | -$2M | ﹤0.01% | 1398 |
|
|
2025
Q1 | $12.7M | Sell |
255,238
-155,818
| -38% | -$7.97M | ﹤0.01% | 1261 |
|
|
2024
Q4 | $18.4M | Buy |
411,056
+142,543
| +53% | +$6.77M | 0.01% | 1178 |
|
|
2024
Q3 | $12.9M | Sell |
268,513
-427,934
| -61% | -$20.6M | ﹤0.01% | 1308 |
|
|
2024
Q2 | $35.5M | Buy |
696,447
+609,118
| +697% | +$33.4M | 0.01% | 727 |
|
|
2024
Q1 | $4.74M | Buy |
87,329
+49,647
| +132% | +$2.59M | ﹤0.01% | 1893 |
|
|
2023
Q4 | $2.12M | Buy |
37,682
+32,531
| +632% | +$1.84M | ﹤0.01% | 2877 |
|
|
2023
Q3 | $318K | Sell |
5,151
-11,446
| -69% | -$724K | ﹤0.01% | 3062 |
|
|
2023
Q2 | $980K | Sell |
16,597
-25,363
| -60% | -$1.61M | ﹤0.01% | 2321 |
|
|
2023
Q1 | $3.1M | Sell |
41,960
-62,497
| -60% | -$4.82M | ﹤0.01% | 1882 |
|
|
2022
Q4 | $7.63M | Sell |
104,457
-57,417
| -35% | -$4.54M | ﹤0.01% | 1353 |
|
|
2022
Q3 | $13.5M | Buy |
161,874
+10,932
| +7% | +$940K | 0.01% | 746 |
|
|
2022
Q2 | $12M | Buy |
150,942
+141,452
| +1,491% | +$13.7M | 0.01% | 938 |
|
|
2022
Q1 | $988K | Sell |
9,490
-46,008
| -83% | -$3.81M | ﹤0.01% | 2415 |
|
|
2021
Q4 | $4.17M | Sell |
55,498
-143,813
| -72% | -$10.1M | ﹤0.01% | 1841 |
|
|
2021
Q3 | $12.9M | Sell |
199,311
-22,537
| -10% | -$1.38M | 0.01% | 1058 |
|
|
2021
Q2 | $13.4M | Sell |
221,848
-7,829
| -3% | -$463K | 0.01% | 1075 |
|
|
2021
Q1 | $12.4M | Buy |
229,677
+224,090
| +4,011% | +$12.2M | 0.01% | 991 |
|
|
2020
Q4 | $270K | Sell |
5,587
-8,660
| -61% | -$383K | ﹤0.01% | 3595 |
|
|
2020
Q3 | $559K | Buy |
14,247
+1,764
| +14% | +$64.2K | ﹤0.01% | 3157 |
|
|
2020
Q2 | $400K | Sell |
12,483
-162,307
| -93% | -$5.65M | ﹤0.01% | 3525 |
|
|
2020
Q1 | $5.93M | Sell |
174,790
-83,490
| -32% | -$3.34M | ﹤0.01% | 1332 |
|
|
2019
Q4 | $12.4M | Buy |
258,280
+72,970
| +39% | +$3.53M | 0.01% | 1240 |
|
|
2019
Q3 | $9.24M | Sell |
185,310
-102,163
| -36% | -$5.21M | 0.01% | 1343 |
|
|
2019
Q2 | $15.4M | Sell |
287,473
-7,457
| -3% | -$389K | 0.01% | 1085 |
|
|
2019
Q1 | $15.6M | Sell |
294,930
-407,032
| -58% | -$21.2M | 0.01% | 983 |
|
|
2018
Q4 | $33M | Buy |
701,962
+297,162
| +73% | +$15.5M | 0.03% | 531 |
|
|
2018
Q3 | $23.4M | Buy |
404,800
+84
| +0% | +$4.65K | 0.02% | 766 |
|
|
2018
Q2 | $22M | Buy |
404,716
+41,901
| +12% | +$2.08M | 0.02% | 745 |
|
|
2018
Q1 | $17.1M | Buy |
+362,815
| New | +$18.2M | 0.01% | 923 |
|
Other funds holding NTR
VCM
Barclays's NTR Position: Q1 2026 in Review
Barclays reduced its Nutrien (NTR) stake by 85% in Q1 2026, selling an estimated $11.6M and leaving 27,997 shares worth $2.11M. The position accounts for ﹤0.01% of the portfolio, ranked #2328.
Barclays first reported a position in NTR in Q1 2018 and has held it in 33 quarters since. The position peaked at $35.5M in Q2 2024. 747 funds tracked by Wall St. Rank hold NTR as of Q1 2026.
- Barclays held 27,997 shares of Nutrien worth $2.11M as of Q1 2026.
- Barclays sold 162,236 Nutrien shares in Q1 2026, an estimated $11.6M.
- Nutrien made up ﹤0.01% of Barclays's portfolio in Q1 2026, its #2328 holding.
- Barclays first reported a position in Nutrien in Q1 2018 and has held it in 33 quarters since.
- Barclays's Nutrien position peaked at $35.5M in Q2 2024.
- 747 funds tracked by Wall St. Rank held Nutrien as of Q1 2026.
Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.